Very high-dose chemotherapy with autologous peripheral stem cell support in advanced ovarian cancer
- 1 November 1995
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (12) , 1987-1992
- https://doi.org/10.1016/0959-8049(95)00337-1
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Dose intensity analysis of high-dose carboplatin in refractory ovarian carcinoma relative to ageCancer, 2010
- Efficacy and toxicity of very high-dose cisplatin in advanced ovarian carcinoma: 4-year survival analysis and neurological follow-upInternational Journal of Gynecologic Cancer, 1993
- Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancerThe Lancet, 1992
- High-dose platinum chemotherapy in advanced ovarian cancer: A phase II studyGynecologic Oncology, 1992
- Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group.BMJ, 1991
- The calculation of received dose intensity.Journal of Clinical Oncology, 1990
- Cisplatin Combined With Carboplatin: A New Way of Intensification of Platinum Dose in the Treatment of Advanced Ovarian CancerJNCI Journal of the National Cancer Institute, 1990
- JM8, SUCCESSOR TO CISPLATIN IN ADVANCED OVARIAN CARCINOMA?The Lancet, 1983
- Surgery for common epithelial tumors of the ovaryCancer, 1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958